HI

Hiron-Trade Investments & Industrial Buildings Ltd.

HRON | TA

Overview

Corporate Details

ISIN(s):
IL0001500110
LEI:
Country:
Israel
Address:
20 Ben Zvi Rd, 6816215 Tel Aviv
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Hiron develops and manufactures electronic and communication systems for defense and civilian use.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Hiron-Trade Investments & Industrial Buildings Ltd.. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-03-06 18:40
Regulatory News Service
Candidates securities not to be included in the Illiquid list as of May 4th 202…
Hebrew (modern) 245.6 KB
2024-10-28 18:31
Regulatory News Service
Candidates securities not to be included in the Illiquid list as of November 10…
Hebrew (modern) 65.0 KB
2023-10-19 20:07
Regulatory News Service
Candidates securities not to be included in the Illiquid list as of November 5t…
Hebrew (modern) 190.9 KB

Automate Your Workflow. Get a real-time feed of all Hiron-Trade Investments & Industrial Buildings Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Hiron-Trade Investments & Industrial Buildings Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Cantargia Logo
Develops antibody-based drugs targeting IL1RAP for cancer and inflammatory diseases.
Sweden CANTA
Captor Therapeutics S.A. Logo
Develops TPD drugs for oncology and autoimmune disorders, targeting 'undruggable' proteins.
Poland CTX
Developing engineered cellular medicines for regenerative treatment of heart failure.
United Kingdom N/A
Cellectis Logo
Biopharma using gene-editing to create off-the-shelf CAR T-cell cancer therapies.
France ALCLS
Celyad Oncology SA Logo
Clinical-stage biotech developing allogeneic & autologous CAR T-cell therapies for cancer.
Belgium CYAD
Cereno Scientific AB Logo
Clinical-stage biotech developing treatments for rare cardiovascular & pulmonary diseases.
Sweden CRNO
Ceres Power Holdings PLC Logo
Licensing solid oxide tech (SOFC/SOEC) for clean power and green hydrogen to global partners.
United Kingdom CWR
Cessatech A/S Logo
Develops non-invasive pain relief, like a nasal spray, for children.
Denmark CESSA
CHOSA Oncology AB Logo
Develops diagnostics and drug delivery for personalized cancer therapy.
Sweden CHOSA
Cinclus Pharma Holding AB Logo
Late-stage pharma developing a next-gen P-CAB drug for severe GERD and H. pylori.
Sweden CINPHA